A brief review on Group A Streptococcus pathogenesis and vaccine development
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Streptococcus pyogenes, also known as Group A Streptococcus (GAS), is a Gram-positive human-exclusive pathogen, responsible for more than 500 000 deaths annually worldwide. Upon infection, GAS commonly triggers mild symptoms such as pharyngitis, pyoderma and fever. However, recurrent infections or prolonged exposure to GAS might lead to life-threatening conditions. Necrotizing fasciitis, streptococcal toxic shock syndrome and post-immune mediated diseases, such as poststreptococcal glomerulonephritis, acute rheumatic fever and rheumatic heart disease, contribute to very high mortality rates in non-industrialized countries. Though an initial reduction in GAS infections was observed in high-income countries, global outbreaks of GAS, causing rheumatic fever and acute poststreptococcal glomerulonephritis, have been reported over the last decade. At the same time, our understanding of GAS pathogenesis and transmission has vastly increased, with detailed insight into the various stages of infection, beginning with adhesion, colonization and evasion of the host immune system. Despite deeper knowledge of the impact of GAS on the human body, the development of a successful vaccine for prophylaxis of GAS remains outstanding. In this review, we discuss the challenges involved in identifying a universal GAS vaccine and describe several potential vaccine candidates that we believe warrant pursuit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908 · cited 1×
“Acute rheumatic fever (ARF), triggered by an autoimmune response following GAS infection, is one of the major causes of rheumatic heart disease (RHD) leading to high mortality rates in non-industrialized countries [2].”
BackgroundInfluentialStreptococcus Adherence and Colonization
Nobbs, A. H., Lamont, R. J., & Jenkinson, H. F. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00014-09 · Cited by 657 · cited 4×
“These interactions are mediated by GAS adhesion proteins and generate firm adhesion to distinct tissue sites in the human host [37].”
BackgroundInfluentialHyaluronic acid capsule is a virulence factor for mucoid group A streptococci.
Wessels, M. R., Moses, A. E., Goldberg, J. B., & DiCesare, T. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8317 · Cited by 351 · cited 1×
“, revealing that encapsulated GAS strains perform better than non-encapsulated strains at colonization [40].”
BackgroundThe IL-8 Protease SpyCEP/ScpC of Group A Streptococcus Promotes Resistance to Neutrophil Killing
Zinkernagel, A. S., Timmer, A. M., Pence, M. A., Locke, J. B., Buchanan, J. T., Turner, C. E., Mishalian, I., Sriskandan, S., Hanski, E., & Nizet, V. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.07.002 · Cited by 184
Streptococcus pyogenes adhesion and colonization
Brouwer, S., Barnett, T. C., Rivera‐Hernandez, T., Rohde, M., & Walker, M. J. (2016) · FEBS Letters · doi:10.1002/1873-3468.12254 · Cited by 113 · cited 2×
“Most of the GAS pathogens are then engulfed; however, one of the vital characteristics of GAS is to ‘hide’ within a human cell, or at the endothelial barrier, leaving the host asymptomatic for a few days post-invasion [44].”
Background
Cited by
(2026) · doi:10.1128/mbio.03801-25 · Cited by 1
Metadata
- Authors
- Castro, S. A., & Dorfmueller, H. C.
- Venue
- Royal Society Open Science
- Publisher
- The Royal Society
- Published
- 2021-03
- Volume
- 8
- Issue
- 3
- Pages
- 201991-201991
- ISSN
- 2054-5703 (ISSN-L)
- OpenAlex
- W3135042422
- Cited by
- 82
- References
- 5
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.